Induction of Indoleamine 2,3-Dioxygenase in Tumor Cells Transplanted into Allogeneic Mouse: Interferon-γ is the Inducer
The major catabolic pathway of tryptophan in mammals is the kynurenine pathway. In adult young man in fact about 90% of dietary tryptophan is metabolized along this pathway (Fig. 1) (Wolf, 1974). Although it has long been generally accepted that “hepatic” L-tryptophan 2,3-dioxygenase (tryptophan pyrrolase) is the sole enzyme that catalyzes the first step of this pathway, recent studies have revealed that another enzyme called indoleamine 2,3-dioxygenase (IDO), which catalyzes the same reaction as “hepatic” enzyme, does occur in various “extra-hepatic” organs of mammals [mouse (Yoshida et al., 1980; Yoshida et al., 1981), rat (Cook et al., 1980), rabbit (Hayaishi et al., 1975 and human (Yamazaki et al., 1985)].
KeywordsConditioned Medium Chlamydia Trachomatis Kynurenic Acid Kynurenine Pathway Tryptophan Depletion
Unable to display preview. Download preview PDF.
- de la Maza, L.M., and Peterson, E.M., 1988, Dependence of the in vitro antiproliferative activity of recombinant human γ-interferon on the concentration of tryptophan in culture media, Cancer Res., 48: 346–350.Google Scholar
- Hayaishi, O., Hirata, F., Fujiwara, M., Ohnishi, T., and Nukiwa, T., 1975, Proc. FEBS Meet., 10: 131–141.Google Scholar
- Murray, H.W., Sudol, A.S., Wellner, D., Oca, M.J., Granger, A.M., Libby, D.M., Rothemel, C.D., and Rubin, B.Y., 1989, Role of tryptophan degradation in respiratory burst-independent an timicrobial activity of gamma interferon-stimulated human macrophages, Infect. Immun., 57: 845–849.PubMedGoogle Scholar
- Takikawa, O., Kuroiwa, T., Yamazaki, F., and Kido, R., 1988, Mechanism of interferon-γ action: characterization of indoleamine 2,3-dioxygenase in cultured human cell induced by interferon-7 and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J. Biol. Chem., 263: 2041–2048.PubMedGoogle Scholar
- Wolf, H., 1974, Studies on tryptophan metabolism in man, Scand. J. Clin. Lab. Invest., 33:Suppl. 136.Google Scholar